Point-of-Care Hemoglobin A1c
- 8 October 2019
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 322 (14), 1404-1405
- https://doi.org/10.1001/jama.2019.14063
Abstract
A 57-year-old white man with obesity and hypertension presents for a primary care visit, during which he expresses concern about having diabetes. He reports no symptoms of hyperglycemia, such as frequent urination, increased thirst, fatigue, or visual changes, and had no known family history of diabetes. A series of blood tests had recently been obtained (Table). His body mass index (BMI) is 33.9 and his blood pressure is 160/90 mm Hg. The patient wants to know if a test could be done in the office to determine if he has diabetes.This publication has 9 references indexed in Scilit:
- The National Glycohemoglobin Standardization Program: Over 20 Years of Improving Hemoglobin A1c MeasurementClinical Chemistry, 2019
- Accuracy of a Point-of-Care Hemoglobin A1c AssayJournal of Diabetes Science and Technology, 2019
- Performance of point-of-care HbA1ctest devices: implications for use in clinical practice – a systematic review and meta-analysiscclm, 2016
- Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2015
- Selecting an A1C Point-of-Care InstrumentDiabetes Spectrum, 2015
- Three of 7 Hemoglobin A1c Point-of-Care Instruments Do Not Meet Generally Accepted Analytical Performance CriteriaClinical Chemistry, 2014
- A1C Versus Glucose Testing: A ComparisonDiabetes Care, 2011
- Glucose-Independent, Black–White Differences in Hemoglobin A1cLevelsAnnals of Internal Medicine, 2010